Run3D Limited, a biotechnology spin-out company from The University of Oxford, was founded in 2012 by Dr. Jessica Bruce (Leitch). The company's mission is to develop an affordable, easy-to-use, and scientifically accurate 3D gait analysis system that can be incorporated into clinicians' day-to-day practice. With a focus on gait re-training, Run3D aims to treat a range of lower-limb injuries using highly specialized and evidence-based procedures. The company's recent £25.00K Seed Round investment at 18 December 2013 was secured from Oxford Technology Management.
Run3D Limited's slogan "Helping you move better, reduce injuries and run faster with Run3D's data-driven 3D gait analysis solution" encapsulates its commitment to leveraging advanced technology and evidence-based assessment to deliver innovative and unique services within the Health Care industry.
By collaborating with leading Podiatrists and Physiotherapists, Run3D integrates its technology with treatment recommendations, offering a holistic approach to address orthopedic and musculoskeletal issues. Its real-time feature sets the groundwork for an effective and personalized approach to gait retraining, making a significant impact on injury recovery and performance enhancement.
No recent news or press coverage available for Run3D Limited.